ArticleJournal of the American Society of Nephrology : JASN2025

Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD.

Vikas S Sridhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.